Cargando…

Editorial: Interstitial Lung Disease Around the World

Detalles Bibliográficos
Autores principales:	Wijsenbeek, Marlies, Lee, Joyce S., Udwadia, Zarir, Kreuter, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971624/ https://www.ncbi.nlm.nih.gov/pubmed/35372425 http://dx.doi.org/10.3389/fmed.2022.865334

Ejemplares similares

The world of rare interstitial lung diseases
por: Buschulte, Katharina, et al.
Publicado: (2023)

Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022)

Managing Fatigue in Patients With Interstitial Lung Disease
por: Kahlmann, Vivienne, et al.
Publicado: (2020)

The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021)

Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era
por: Nakshbandi, Gizal, et al.
Publicado: (2021)

Health Related Quality of Life in Interstitial Lung Disease: Can We Use the Same Concepts Around the World?
por: Aronson, Kerri I., et al.
Publicado: (2021)

Where are the gaps in education in the field of rare lung disease? Perspectives from the ERN-LUNG educational programme survey
por: Powell, Pippa, et al.
Publicado: (2019)

Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy
por: Udwadia, Zarir F., et al.
Publicado: (2022)

Exhaled breath analysis in interstitial lung disease
por: van der Sar, Iris G., et al.
Publicado: (2023)

Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021)

Role of the internet of medical things in care for patients with interstitial lung disease
por: Nakshbandi, Gizal, et al.
Publicado: (2023)

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis
por: Udwadia, Zarir F., et al.
Publicado: (2015)

The flare of care for rare: per aspera ad astra for rare lung diseases!
por: Wijsenbeek, Marlies, et al.
Publicado: (2023)

Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World
por: Polke, Markus, et al.
Publicado: (2021)

A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Dyspnoea and cough in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial
por: Volkmann, Elizabeth R, et al.
Publicado: (2022)

Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
por: Guiot, Julien, et al.
Publicado: (2023)

Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases
por: Sambataro, Gianluca, et al.
Publicado: (2022)

Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
por: Korsten, Peter, et al.
Publicado: (2021)

Research highlights from the 2018 ERS International Congress: interstitial lung diseases
por: Alfaro, Tiago M., et al.
Publicado: (2019)

ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly
por: Dupin, Clairelyne, et al.
Publicado: (2020)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2018)

Interstitial lung disease:  course report
por: Kreuter, Michael, et al.
Publicado: (2020)

Feasibility of online home spirometry in systemic sclerosis–associated interstitial lung disease: a pilot study
por: Moor, Catharina C, et al.
Publicado: (2020)

ERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis
por: Molina-Molina, Maria, et al.
Publicado: (2022)

Educational aspects of rare and orphan lung diseases
por: Alfaro, Tiago M., et al.
Publicado: (2021)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2016)

Oxaliplatin-induced lung fibrosis
por: Shah, Arpan, et al.
Publicado: (2009)

ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly
por: Guler, Sabina A., et al.
Publicado: (2022)

Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases
por: Bonella, Francesco, et al.
Publicado: (2022)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2019)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021)

Clinical Genetics in Interstitial Lung Disease
por: Newton, Chad A., et al.
Publicado: (2018)

Acute Exacerbation in Interstitial Lung Disease
por: Leuschner, Gabriela, et al.
Publicado: (2017)

Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019)

Role of the Microbiome in Interstitial Lung Diseases
por: Chioma, Ozioma S., et al.
Publicado: (2021)

Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)

Editorial: Lung Ultrasound and COVID-19 Interstitial Pneumonia in Different Medical Care Settings
por: Vetrugno, Luigi, et al.
Publicado: (2022)

Post-COVID lung fibrosis: The tsunami that will follow the earthquake
por: Udwadia, Zarir F, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o0eekg028b1fn8bvvov3sklurq